by Brian Garst
American Thinker
Joe Biden has left the White House, as have his inflationary policies. Unfortunately, the consequences from his administration’s blame dodging for the high cost of everything remain dangerously intact.
One of Biden’s many scapegoats were Pharmacy Benefit Managers (PBMs), who are employed by both private and government health plans to negotiate with drug manufacturers to bring down prescription costs. PBMs improve market efficiency and save consumers money, but in Biden’s world, they’re another politically convenient culprit somehow behind the runaway inflation of the last four years.
An eleventh-hour report from Biden’s Federal Trade Commission (FTC) fails to convincingly substantiate his charges. The report declares that PBMs “charge significant markups for cancer, HIV, and other critical specialty generic drugs.”